Kyverna Therapeutics (KYTX) Earnings Date & Reports
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYTX is expected to report earnings to rise 17.54% to -101 cents per share on August 18
Q2'25
Est.
$-1.02
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.11
The last earnings report on March 27 showed earnings per share of -86 cents, beating the estimate of -94 cents. With 121.19K shares outstanding, the current market capitalization sits at 143.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KYTX showed earnings on March 27, 2025. You can read more about the earnings report here.